22/04/2013 Guerbet at ISMRM
Salt Lake City, Utah - 20-26 April 2013
21/03/2013 FDA Approves Dotarem®
FDA Approves Dotarem® (gadoterate meglumine), first macrocyclic and ionic gadolinium-based contrast agent in USA
Guerbet LLC will be exhibiting at the 2013 World Conference on Interventional Oncology (WCIO) in New York from May 16-19, 2013. (www.wcio2013.org) Visit us at the Hilton New York. Guerbet is also pleased to be a supporter of the 2013 WCIO Fellows’ Scholarship Fund.
Guerbet will participate in the 2013 Society of Interventional Radiology Annual Scientific Meeting. This premier Interventional event is held from Saturday through Thursday at The Ernest N. Morial Convention Center in New Orleans, LA. Come visit the Guerbet booth #531 in the...
21/02/2012 2013 American College of Cardiology (ACC)
Guerbet will participate in the American College of Cardiology 62nd Annual Scientific Session and Expo being held March 9-11, 2013 at the Moscone Center in San Francisco, CA. The annual meeting of the American College of Cardiology is unsurpassed among clinical cardiology meetings and is...